MedTrace Logo

Myocardial Ischemia and Transfusion

NCT02619136 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3501

Last updated 2023-07-27

No results posted yet for this study

Summary

MINT: A pilot, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in patients with myocardial infarction.

Conditions

Interventions

PROCEDURE

Transfusion

Red Blood Cell Transfusion

Sponsors & Collaborators

  • Canadian Blood Services

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Paul Hébert, MD · Centre Hospitalier de l'Universite de Montreal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619136 on ClinicalTrials.gov